Xinyi Wang Selected Research

Xinyi Wang Research Topics

Disease

66	Neoplasms (Cancer) 08/2022 - 11/2011
12	Neoplasm Metastasis (Metastasis) 08/2022 - 02/2016
12	Carcinogenesis 11/2020 - 07/2014
11	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2015
11	Wounds and Injuries (Trauma) 01/2022 - 11/2011
11	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2016
10	Inflammation (Inflammations) 07/2022 - 01/2017
9	Infections 01/2022 - 12/2014
8	COVID-19 01/2022 - 01/2020
7	Cicatrix (Scar) 01/2022 - 01/2009
6	Hypothyroidism 04/2022 - 08/2015
6	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
6	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 12/2015 - 01/2009
5	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2019
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
5	Hypoxia (Hypoxemia) 01/2022 - 01/2019
5	Fibrosis (Cirrhosis) 11/2021 - 01/2017
5	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2014
4	Body Weight (Weight, Body) 12/2021 - 01/2018
4	Malaria 01/2021 - 01/2020
4	Cognitive Dysfunction 01/2020 - 01/2015
4	Thyroid Diseases (Thyroid Disease) 06/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 06/2022 - 01/2017
3	Dementia (Dementias) 01/2022 - 01/2020
3	Ischemia 01/2022 - 01/2020
3	Ischemic Stroke 01/2022 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2017
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2020
3	Autoimmune Diseases (Autoimmune Disease) 08/2019 - 01/2017
2	Leukemia 06/2022 - 01/2022
2	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 05/2022 - 01/2021
2	Urolithiasis 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 01/2022 - 01/2021
2	Brain Injuries (Brain Injury) 01/2022 - 08/2016
2	Pain (Aches) 01/2022 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2019
2	Heart Failure 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2013
2	Postoperative Pain 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 11/2021 - 01/2017
2	Zika Virus Infection 11/2021 - 10/2019
2	Pneumonia (Pneumonitis) 02/2021 - 01/2020
2	Hyperglycemia 01/2021 - 11/2011

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2013
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
11	Pharmaceutical PreparationsIBA 08/2022 - 02/2017
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2018
9	CytokinesIBA 01/2022 - 01/2017
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 02/2013
7	VaccinesIBA 01/2022 - 08/2018
7	Biological ProductsIBA 01/2022 - 05/2017
7	MicroRNAs (MicroRNA)IBA 03/2020 - 01/2015
7	Collagen Type VIIIBA 12/2015 - 06/2007
6	Messenger RNA (mRNA)IBA 06/2022 - 04/2017
6	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2017
6	Circular RNAIBA 01/2022 - 01/2019
6	EnzymesIBA 10/2021 - 06/2007
6	LigandsIBA 01/2021 - 01/2016
5	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2017
5	CollagenIBA 10/2021 - 06/2007
4	PlatinumIBA 01/2022 - 01/2019
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2022 - 08/2016
3	Etoposide (VP 16)FDA LinkGeneric 06/2022 - 11/2016
3	ProteomeIBA 06/2022 - 01/2019
3	Protein Isoforms (Isoforms)IBA 06/2022 - 01/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 11/2011
3	ProdrugsIBA 01/2022 - 01/2019
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	Tapentadol FDA Link 01/2022 - 01/2020
3	Long Noncoding RNAIBA 01/2022 - 08/2019
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 01/2020
3	AntibodiesIBA 11/2021 - 04/2014
3	DN604IBA 01/2021 - 01/2019
3	CateninsIBA 01/2021 - 01/2018
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2016
3	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 11/2019 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2016
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 07/2014
3	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 07/2014
2	Serotonin (5 Hydroxytryptamine)IBA 10/2022 - 01/2016
2	SodiumIBA 01/2022 - 10/2019
2	SphingolipidsIBA 01/2022 - 01/2019
2	IronIBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2021
2	AntioxidantsIBA 12/2021 - 09/2018
2	KynurenineIBA 02/2021 - 01/2021
2	Antimalarials (Antimalarial Agents)IBA 01/2021 - 01/2021
2	CreatinineIBA 01/2021 - 12/2020
2	Gemcitabine FDA Link 01/2021 - 11/2020

Therapy/Procedure

41	Therapeutics 08/2022 - 11/2011
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
3	Immunotherapy 02/2021 - 10/2020
2	Photothermal Therapy 01/2022 - 10/2021
2	Ambulatory Care (Outpatient Care) 01/2022 - 12/2014